---
title: "Mesenchymal Stem Cells and Autoimmune Conditions: Immune Modulation Explained"
description: "How mesenchymal stem cells interact with the immune system, what research shows for lupus, RA, MS and IBD, and how we screen candidates. An investigational therapy."
canonical: "https://dreambody.clinic/stem-cell-therapy-lupus-autoimmune-conditions/"
---

# Mesenchymal Stem Cells and Autoimmune Conditions: Immune Modulation Explained

Living with an autoimmune condition such as lupus, rheumatoid arthritis, multiple sclerosis or inflammatory bowel disease often means years of appointments, medication changes, flares and uncertainty. Many patients do well on modern treatments. Others still struggle with symptoms or side effects, or want to understand every option being researched.

Mesenchymal stem cell (MSC) therapy is one of those options. **For autoimmune conditions, MSC therapy is investigational.** It is not FDA-approved for any autoimmune disease, the research is ongoing, and results vary widely. This article explains what immune modulation means, summarizes the current research by condition, and describes how Dream Body Clinic evaluates people who ask about it.

## What "Immune Modulation" Means

In autoimmune disease, the immune system mistakenly targets the body’s own tissues: the joints in RA, multiple organs in lupus, the nervous system in MS, and the gut in Crohn’s disease and ulcerative colitis.

MSCs are of interest to researchers because, in laboratory and clinical studies, they appear to interact with immune cells. They release signaling molecules that may:

- influence the activity of certain immune cells, including T cells and B cells,
- encourage regulatory pathways that help calm immune responses, and
- reduce the signals that drive inflammation.

This is called **immunomodulation**. It means *adjusting* the immune response, not switching it off or replacing it. Scientists are still working out how lasting these effects are, how much they vary between people, and which patients, if any, benefit most.

## What the Research Shows by Condition

The research below is summarized at a general level. Before publishing, our medical team will add specific study citations. We encourage you to read the studies yourself and discuss them with your specialist.

### Lupus (Systemic Lupus Erythematosus)

MSCs have been studied in lupus, including in some patients whose disease did not respond to standard therapy. Some studies report improvements in disease activity measures, while others, including some controlled trials, have not shown clear benefit over standard care. The evidence is mixed, and MSC therapy is not an established lupus treatment.

### Rheumatoid Arthritis

Early-phase clinical studies have looked at MSC infusions in RA. They mainly assessed safety and early signs of effect. Some reported improvements in symptoms or inflammatory markers. Larger, controlled studies are needed.

### Multiple Sclerosis

MS has been studied with several types of cell therapy. Note that some of the strongest MS data relate to a *different* procedure, autologous hematopoietic stem cell transplantation (aHSCT), which is not what MSC therapy is. MSC studies in MS have mainly been early-phase studies focused on safety, with mixed signals on effectiveness.

### Crohn’s Disease and Ulcerative Colitis

MSCs have been studied in inflammatory bowel disease, including locally delivered MSCs for certain complex fistulas in Crohn’s disease. Evidence for IV MSCs in IBD more broadly is still early.

### Other Conditions

Dream Body Clinic also receives inquiries about Hashimoto’s thyroiditis, psoriasis, fibromyalgia, myasthenia gravis and other conditions. The research base for most of these is limited.

## Our IV Protocols

For people with autoimmune and chronic inflammatory conditions, Dream Body Clinic offers protocols based on **intravenous MSC infusions**. Our IV tiers are 100 million, 200 million and 300 million cells. Your physician will discuss which, if any, is appropriate after reviewing your records.

Our cells are allogeneic (from a donor). They are derived from Wharton’s jelly and placenta donated after healthy births, produced in our own COFEPRIS-licensed laboratory, tested by third-party laboratories, and never frozen.

## Your Medications: Coordinate With Your Specialist

**Do not stop or change your autoimmune medications on your own.** Stopping immunosuppressants, biologics or steroids suddenly can cause serious flares, and stopping steroids abruptly can be dangerous.

Our medical team reviews every medication you take as part of the case review. We may discuss timing around common anti-inflammatory medications. Any change to prescribed medication must be planned with the physician who prescribed it. We encourage you to keep your rheumatologist, neurologist or gastroenterologist informed.

## Questions to Ask Your Specialist (and Us)

1. What does the current evidence say about MSCs for my specific condition?
2. How might an MSC infusion interact with my current medication?
3. Are there clinical trials I could join instead?
4. What symptoms or lab results should we track before and after?
5. What would make me a poor candidate?
6. What are the risks, given my condition and medications?
7. What follow-up will I have, and who will manage any problems at home?

## Who May Not Be a Candidate

Our physicians may advise against treatment for people with:

- active, uncontrolled infection,
- certain active cancers,
- severe organ involvement or medical instability that makes travel unsafe,
- pregnancy, and
- expectations of a guaranteed result or of stopping medication.

## Realistic Expectations

If you choose to go ahead, it helps to know:

- responses vary widely; some people report improvement, and others notice no change,
- any changes, if they occur, are typically assessed over 3–6 months,
- autoimmune conditions naturally flare and settle over time, which makes it hard to judge any single treatment, and
- we follow up remotely at 3, 6 and 12 months, and we encourage you to track symptoms and lab work with your own doctors.

## How a Records Review Works

Because autoimmune conditions are complex, our process starts with a careful review rather than a booking:

1. **Initial conversation.** A 30–45 minute call with a patient coordinator and our medical team to understand your history and goals.
2. **Records submission.** You send recent lab work (for example inflammatory markers, antibody panels and organ function tests), specialist notes, imaging and a full medication list.
3. **Physician assessment.** Our doctors review whether an MSC protocol is reasonable to discuss, which protocol, and any safety concerns.
4. **Honest recommendation.** If we don’t think treatment is appropriate, we will tell you.
5. **Planning.** If you choose to go ahead, we coordinate dates, travel and a follow-up plan, and we encourage you to share it with your specialist.

## Frequently Asked Questions

**Is MSC therapy a cure for lupus or MS?** No. It is an investigational therapy, not a cure, and it is not FDA-approved for autoimmune disease.

**Can I stop my medication after treatment?** Never stop or reduce prescribed medication without guidance from your prescribing physician.

**Is this the same as a stem cell transplant?** No. Hematopoietic stem cell transplantation (HSCT) is a different, more intensive procedure. MSC therapy is an infusion of donor-derived mesenchymal cells.

**What are the side effects?** Studies generally report that MSC infusions are well tolerated. Transient fever is the most commonly reported effect. Long-term data are limited.

**How long is the visit?** Usually a few days, including blood work, the infusion and observation.

## Request a Physician Records Review

If you want to understand whether MSC therapy is worth discussing for your condition, send us your records for a free, no-obligation review. We’ll give you an honest view of what we know and don’t know. Call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net.

---

*Disclaimer: MSC therapy for autoimmune conditions is investigational. Results vary from person to person. Stem cell therapies described here are not FDA-approved and are provided in Mexico under COFEPRIS licensing. This content is educational and is not medical advice. Never change prescribed medication without your physician. Consult your physician before making treatment decisions.*
